TY - JOUR
T1 - Etanercept prevents airway hyperresponsiveness by protecting neuronal M 2 muscarinic receptors in antigen-challenged guinea pigs
AU - Nie, Zhenying
AU - Jacoby, David B.
AU - Fryer, Allison D.
PY - 2009/1
Y1 - 2009/1
N2 - Background and purpose: Increased tumour necrosis factor-α (TNF-α) is associated with airway hyperreactivity in antigen-challenged animals. In human asthmatics, TNF-α is increased and blocking it prevents airway hyperreactivity in some asthmatic patients. However, the mechanisms by which TNF-α mediates hyperreactivity are unknown. Airway hyperreactivity can be caused by dysfunction of neuronal M 2 muscarinic receptors that normally limit acetylcholine release from parasympathetic nerves. Here we test whether blocking TNF-α receptors with etanercept prevents M 2 receptor dysfunction and airway hyperreactivity in antigen-challenged guinea pigs. Experimental approach: Ovalbumin-sensitized guinea pigs were challenged by inhalation of antigen. Some animals received etanercept (3 mg kg -1 i.p.) 3 h before challenge. 24 h after challenge, airway hyperreactivity and M 2 receptor function were tested. Inflammatory cells in bronchoalveolar lavage, blood and lung were counted. TNF-α and its receptors were detected by real-time RT-PCR and immunocytochemistry in parasympathetic nerves from humans and guinea pigs and in human neuroblastoma cells. Key results: Antigen-challenged animals were hyperreactive to vagal stimulation and neuronal M 2 receptors were dysfunctional. Both M 2 receptor dysfunction and airway hyperreactivity were prevented by etanercept. Etanercept reduced eosinophils around airway nerves, and in blood, bronchoalveolar lavage and airway smooth muscle. Also, TNF-α decreased M 2 receptor mRNA in human and guinea pig parasympathetic neurons. Conclusions and implications: Tumour necrosis factor-α may contribute to M 2 receptor dysfunction and airway hyperreactivity directly by decreasing receptor expression and indirectly by promoting recruitment of eosinophils, containing major basic protein, an M 2 antagonist. This suggests that etanercept may be beneficial in treatment of allergic asthma.
AB - Background and purpose: Increased tumour necrosis factor-α (TNF-α) is associated with airway hyperreactivity in antigen-challenged animals. In human asthmatics, TNF-α is increased and blocking it prevents airway hyperreactivity in some asthmatic patients. However, the mechanisms by which TNF-α mediates hyperreactivity are unknown. Airway hyperreactivity can be caused by dysfunction of neuronal M 2 muscarinic receptors that normally limit acetylcholine release from parasympathetic nerves. Here we test whether blocking TNF-α receptors with etanercept prevents M 2 receptor dysfunction and airway hyperreactivity in antigen-challenged guinea pigs. Experimental approach: Ovalbumin-sensitized guinea pigs were challenged by inhalation of antigen. Some animals received etanercept (3 mg kg -1 i.p.) 3 h before challenge. 24 h after challenge, airway hyperreactivity and M 2 receptor function were tested. Inflammatory cells in bronchoalveolar lavage, blood and lung were counted. TNF-α and its receptors were detected by real-time RT-PCR and immunocytochemistry in parasympathetic nerves from humans and guinea pigs and in human neuroblastoma cells. Key results: Antigen-challenged animals were hyperreactive to vagal stimulation and neuronal M 2 receptors were dysfunctional. Both M 2 receptor dysfunction and airway hyperreactivity were prevented by etanercept. Etanercept reduced eosinophils around airway nerves, and in blood, bronchoalveolar lavage and airway smooth muscle. Also, TNF-α decreased M 2 receptor mRNA in human and guinea pig parasympathetic neurons. Conclusions and implications: Tumour necrosis factor-α may contribute to M 2 receptor dysfunction and airway hyperreactivity directly by decreasing receptor expression and indirectly by promoting recruitment of eosinophils, containing major basic protein, an M 2 antagonist. This suggests that etanercept may be beneficial in treatment of allergic asthma.
KW - Airway hyperreactivity
KW - Asthma
KW - Eosinophil
KW - TNF-α
UR - http://www.scopus.com/inward/record.url?scp=65549128183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65549128183&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5381.2008.00045.x
DO - 10.1111/j.1476-5381.2008.00045.x
M3 - Article
C2 - 19134001
AN - SCOPUS:65549128183
SN - 0007-1188
VL - 156
SP - 201
EP - 210
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 1
ER -